Ophthamology Times Webinar Series

Impactful Tips to Integrate the

CATALYS® Precision Laser System

Tues, Aug 16 at 7:00 pm EDT • Thurs, Aug 25 at 8:00 pm EDT

SUMMARY

This presentation will provide an overview of how the CATALYS® Precision Laser System is engineered for outstanding clinical outcomes and allows the cataract surgeon to make their process efficient.

LEARNING OBJECTIVES

		Identify core benefits for surgeons and patients from the purchase of a femtosecond laser system
		Select appropriate messaging to include in patient education materials that explain the benefits of a femtosecond laser
		Discuss ways in which the introduction of the CATALYS® Precision Laser System impacts day- to-day workflow in the surgical setting
		Describe the broad range of cataract cases in which the CATALYS® Precision Laser System can be used successfully to optimize patient outcomes
		PRESENTER Keith A. Walter, MD Professor, Ophthalmology Wake Forest Baptist Medical Center Winston-Salem, NC

See Indications and Important Safety Information Below for the

CATALYS® Precision Laser System

Rx Only

INDICATIONS: The OptiMedica CATALYS® Precision Laser System is indicated for use in patients undergoing cataract surgery for removal of the crystalline lens. Intended uses in cataract surgery include anterior capsulotomy, phacofragmentation, and the creation of single plane and multi-plane arc cuts/incisions in the cornea, each of which may be performed either individually or consecutively during the same procedure.

CONTRAINDICATIONS: Should not be used in patients with corneal ring and/or inlay implants, severe corneal opacities, corneal abnormalities, significant corneal edema or diminished aqueous clarity that obscures OCT imaging of the anterior lens capsule, patients younger than 22 years of age, descemetocele with impending corneal rupture, and any contraindications to cataract surgery.

PRECAUTIONS: The CATALYS® System has not been adequately evaluated in patients with a cataract greater than Grade 4 (via LOCS III); therefore no conclusions regarding either the safety or effectiveness are presently available.

ADVERSE EFFECTS: Complications include mild Petechiae and subconjunctival hemorrhage due to vacuum pressure of the LIQUID OPTICS Interface suction ring. Potential complications and adverse events include those generally associated with the performance of capsulotomy and lens fragmentation, or creation of a partial-thickness or full-thickness cut or incision of the cornea.

CAUTION: Should be used only by qualified physicians who have extensive knowledge of the use of this device and have been trained and certified by Abbott Medical Optics/OptiMedica.

ATTENTION: Reference the labeling for a complete listing of Indications and Important Safety Information.

© 2016 Abbott Medical Optics Inc. OPTIMEDICA and CATALYS are trademarks
owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates.

PP2015CT1096

This email was sent by:

{{ site_settings.company_name }}, {{ site_settings.company_street_address_1 }}, {{ site_settings.company_city }}, {{ site_settings.company_state }} {{ site_settings.company_zip }}

SUMMARY

LEARNING OBJECTIVES

PRESENTER